AI-Powered Innovation: Facilitating the Journey From Ideation to Commercialization

NutrifyToday’s artificial intelligence (AI) may revolutionize the presentation of dietary supplements as effective adjuvants in the area of cognition & neuroprotection, crucial in managing the implications of aging populations.

NutrifyGenie AI, NutrifyToday’s AI-powered innovation platform, is redefining and reshaping the landscape of the nutraceutical industry by facilitating the journey from ideation to commercialization. NutrifyGenie AI has ventured into challenging territories in a groundbreaking development, focusing on cognition & neuroprotection. By conducting an exhaustive analysis of big data on clinical trials, including both successful and failed trials, as well as pathway hypotheses and protein binding patterns, NutrifyGenie AI has developed a product specifically designed to potentially support mainline therapies in cognition & neuroprotection as an effective adjuvant. This initiative has resulted in a well-evaluated product, recognized globally and earning a spot at the prestigious Nutrition 2024 event in Chicago, hosted by the American Society of Nutrition. The abstract, with submission ID 1758130, aims to revolutionize the nutraceutical field by presenting these supplements as viable adjuvants supporting the mainline therapy of cognition & neuroprotection.

The formulation of this new product, codenamed ALZ-AD+, represents a significant advance in dietary supplements as potential effective adjuvants in managing cognition & neuroprotection conditions. It leverages anti-inflammatory and neuroprotective properties derived from natural sources. These components may support mainline therapies in neurogenesis, offering a multi-faceted approach to tackling the condition’s progression and cognitive decline. A large multicentric clinical study is being planned to validate this innovation.

Cognition & neuroprotection requires a novel approach to management that extends beyond symptomatic relief, and with NutrifyGenie AI, not only has the product development cycle and process been optimized, the formula has been vetted for compliance using the platform, for 11 regulatory jurisdictions.

NutrifyToday’s ALZ-AD+ stands as a testament to the power of AI in revolutionizing healthcare. It merges cutting-edge technology with natural ingredients to create a new path in dietary supplements as effective adjuvants. Upon successful completion of clinical trials, this innovative approach will underscore NutrifyToday’s commitment to advancing dietary supplements as responsible solutions, marking a pivotal shift in supporting neurodegenerative conditions.

Learn more about the latest in AI and emerging tech in the natural products industry from the

Naturally Informed virtual conference Supply Chain & Delivery Systems: Mastering the Market, now available on demand. In the session A Spotlight on India and Geopolitical Implications across Supply Chains, Nutrify Today’s Chief Catalyst Amit Srivastava provides an update on the India Nutra scene as well as an overview on NutrifyGenie AI.